Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Mini Oral session - Thoracic cancers

A phase I study to evaluate safety and efficacy of BPI-7711 in EGFRm+/T790M+ advanced or recurrent NSCLC patients

Date

23 Nov 2019

Session

Mini Oral session - Thoracic cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Sheng Yang

Citation

Annals of Oncology (2019) 30 (suppl_9): ix157-ix181. 10.1093/annonc/mdz437

Authors

Y. Shi1, J. Fang2, Y. Shu3, D. Wang4, H. Yu4, Y. Zhao5, L. Zhang6, B. Zhu7, X. Li8, G. Chen9, J. Shi10, R. Zheng11, J. Huang12, S. Yang13, J. Long2, W. Gao3, M. Greco14, G. Hu15, X. Li16

Author affiliations

  • 1 Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100021 - Beijing/CN
  • 2 Oncology, Beijing Cancer Hospital, Beijing/CN
  • 3 Cancer Center, Jiangsu Province Hospital, Nanjing/CN
  • 4 Oncology, Chongqing Cancer Hospital, Chongqing/CN
  • 5 Oncology, Henan Cancer Hospital, Zhengzhou/CN
  • 6 Oncology, Yantai Yuhuangding Hospital, Yantai/CN
  • 7 Oncology, The Second Affiliated Hospital of Army Medical University, PLA, Chongqing/CN
  • 8 Oncology, The first affiliated hospital of Zhengzhou University, Zhengzhou/CN
  • 9 Oncology, Harbin Medical University Cancer Hospital, Harbin/CN
  • 10 Oncology, Shandong Linyi Tumor Hospital, Linyi/CN
  • 11 Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu/CN
  • 12 Oncology, The First Affiliated Hospital of Soochow University, Suzhou/CN
  • 13 Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing/CN
  • 14 Research And Development, Beta Pharma, Princeton/US
  • 15 Clinical Development, Beta Pharma, Shanghai/CN
  • 16 Clinical Development, Beta Pharma, 200000 - Shanghai/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion led by moderators

Presenter: Byoung Chul Cho

Session: Mini Oral session - Thoracic cancers

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.